Development of Radiographic Contrast Agents for Diagnostic Imaging

For latest version: please go to https://academicentrepreneurship.pubpub.org/pub/tn8b15jm/release/5 Imaging contrast agents, administered intravenously, are diverse, can be used for diagnostic and therapeutic purposes, and have specific regulatory requirements and development considerations. Collaborative relationships between industry and academia may provide the best approach for the development of these agents. Additional opportunities for development and commercialization include software specific for the analysis of contrast-enhanced examinations. There are special considerations for each class of imaging contrast agents with regards to market growth and potential avenues for future development.